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Abstract
A study was performed to compare matrix-assisted laser desorption/ionization-time of ﬂight mass spectrometry (MALDI-TOF-MS),
linked to a recently engineered microbial identiﬁcation database, and two rapid identiﬁcation (ID) automated systems, BD Phoenix
(Becton Dickinson Diagnostic Systems, France) and VITEK-2 (bioMe´rieux, Marcy L’Etoile, France), for the ID of coagulase-negative
staphylococci (CoNS). Two hundred and thirty-four clinical isolates of CoNS representing 20 species were analyzed. All CoNS isolates
were characterized by sodA gene sequencing, allowing interpretation of the ID results obtained using the respective database of each
apparatus. Overall correct ID results were obtained in 93.2%, 75.6% and 75.2% of the cases with the MALDI-TOF-MS, Phoenix and
VITEK-2 systems, respectively. Mis-ID and absence of results occurred in 1.7% and 5.1% of the cases with MALDI-TOF-MS, in 23.1%
and 1.3% with the Phoenix, and in 13.7% and 0.9% with the VITEK-2 systems, respectively. In addition, with the latter automate, 10.3%
of the IDs were proposed with remote possibility. When excluding the CoNS species not included in the databases of at least one of
the three systems, the ﬁnal percentage of correct results, Mis-ID and absence of ID were 97.4%, 1.3% and 1.3% with MALDI-TOF-MS,
79%, 21% and 0% with the Phoenix, and 78.6%, 10.3% and 0.9% with the VITEK-2 system, respectively. The present study demonstrates
the robustness and high sensitivity of our microbial identiﬁcation database used with MALDI-TOF-MS technology. This approach repre-
sents a powerful tool for the fast ID of clinical CoNS isolates.
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Introduction
Coagulase-negative staphylococci (CoNS) are among the
most frequently isolated bacteria in clinical microbiology labo-
ratories. CoNS species are the most commonly reported
strains isolated from the majority of nosocomial bloodstream
infections [1]. They are responsible for bacteraemia, endocar-
ditis, mediastinitis, meningitis and progressive joint destruc-
tion [2–4]. CoNS are commensals of the skin, their virulence
is low in healthy populations and they have long been consid-
ered to be contaminants. Most staphylococci isolated from
humans belong to the Staphylococci epidermidis group or to
the Staphylococci saprophyticus group. The ﬁrst group includes
the species: S. epidermidis, Staphylococci capitis, Staphylococci
hominis, Staphylococci haemolyticus, Staphylococci warneri, Staphy-
lococci caprae, Staphylococci saccharolyticus, Staphylococci paste-
uri and Staphylococci lugdunensis [3]. It should be noted that
some species (i.e. S. haemolyticus, S. lugdunensis and Staphylo-
cocci schleiferi) are more often isolated from severe human
infections such as native valve endocarditis [4].
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The increasing importance of CoNS in hospital-acquired
infections emphasizes the need for an accurate identiﬁcation
of staphylococci at the species level. Bacterial identiﬁcation is
usually achieved using phenotype-based techniques with sys-
tems such as rapid identiﬁcation (ID) automates, which
detect more than 50 phenotypic characters. However, most
commercial identiﬁcation kits and automated systems remain
unable to differentiate between several species of CoNS [5–
7]. Molecular methods targeting the sodA or the tuf genes
are currently favoured for diagnostic purposes. However,
they can be time-consuming and often are expensive [8,9].
Recently, matrix-assisted laser desorption/ionization time-of-
ﬂight mass spectrometry (MALDI-TOF-MS) has been used to
characterize bacteria [10–14]. MALDI-TOF-MS can examine
the pattern of proteins detected directly from intact bacteria.
For a given bacterial strain, MALDI-TOF-MS yields a repro-
ducible spectrum within minutes, consisting of a series of
peaks corresponding to mass-to-charge (m/z) ratios of ions
released from bacterial proteins during laser desorption.
Recently, we engineered a database to identify bacteria
belonging to the Micrococcaceae family [15]. In the present
study, using this database, MS was evaluated for its ability to
identify CoNS at the species level compared to two com-
mercial automated systems. All strains were identiﬁed by
sequencing the sodA gene. The data obtained demonstrate
the superiority of the identiﬁcation obtained by MS com-
pared to that obtained using both the Phoenix Automated
Microbiology (BD Diagnostic Systems, Le Pont de Claix,
France) and the VITEK-2 (bioMe´rieux, Marcy L’Etoile,
France) systems.
Materials and Methods
Study design
Mass spectrometry (MALDI-TOF-MS) and two commercial
microbiological identiﬁcation systems were evaluated and
compared for their ability to identify CoNS isolated from
clinical samples. The automated systems tested were the
Phoenix Automated Microbiology system and the VITEK-2
system. The two automated systems are used daily in the
microbiology laboratories at Raymond Poincare´ hospital and
Ambroise Pare´ hospital, respectively. The spectrometer used
for the analysis at Necker-Enfants Malades hospital in routine
practice was a MALDI-TOF-MS Autoﬂex with the ﬂex con-
trol software (Bruker Daltonics, Bremen, Germany). All
CoNS isolates were identiﬁed at the species level by molecu-
lar methods. It should be noted that the data were obtained
independently and were compared only at the end of the
study.
Bacterial isolates
A total of 234 CoNS isolates representative of 20 species
were studied (Table 1). All isolates were recovered from
cultures performed routinely in two clinical microbiology lab-
oratories (Raymond Poincare´ and Ambroise Pare´ hospitals).
Molecular identiﬁcation
The identiﬁcation of the CoNS isolates at the species level
was obtained by sequencing an internal fragment of the sodA
gene as previously described [8,9]. The partial sodA gene was
ampliﬁed and the PCR product sequenced as previously
described [9] using primers d1 (5¢-CCITAYICITAYGAYGC
IYTIGARCC-3¢) and d2 (5¢-ARRTARTAIGCRTGYTCCCAI
ACRTC-3¢). The nucleotide sequences were analyzed using a
local database of sodAint sequences of Staphylococcus type
strains and the GenBank database.
VITEK-2 system
The method used was described previously [16–18]. Frozen
strains were grown on trypticase soy agar supplemented with
5% sheep blood agar (bioMe´rieux) for 18–24 h at 37C and
subcultured on a new agar plate for an additional 18–24 h at
37C before testing. Bacterial suspensions were prepared
extemporaneously by suspending bacterial isolates in 0.45%
saline to the equivalent of a 0.5–0.63 McFarland turbidity stan-
dard with the VITEK-2 Densichek instrument. The ID-GP
identiﬁcation card is a 64-well plastic card that includes 43
tests. Data were analyzed using VITEK-2 database, version
4.03. The Staphylococcus species and subspecies that can be
identiﬁed with the VITEK-2 system are listed in Table 2.
Phoenix system
The method used was described previously [19]. Brieﬂy, bac-
terial isolates were subcultured on trypticase soy agar sup-
plemented with 5% sheep blood agar (bioMe´rieux) as
described above. The Phoenix ID broth was inoculated with
several bacterial colonies from a pure culture and adjusted
to a 0.5–0.6 McFarland standard using a Crystal Spec Nephe-
lometer (Becton Dickinson Diagnostic Systems). The ID
broth suspension was then poured into the ID side of the
Combo panel (PMIC/ID 13 panel for Gram positive cocci).
The Staphylococcus species or subspecies that can be identi-
ﬁed with Phoenix system are listed in Table 2.
MALDI-TOF-MS
The method used was described previously [15,20]. The
strains were grown on Mueller–Hinton agar and incubated
for 24 h at 37C. An isolated colony was harvested in 10 lL
of sterile water. One microlitre of this mixture was depos-
ited on a target plate in two replicates and allowed to dry at
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room temperature. One microlitre of absolute ethanol was
then added to each well and dried. One microlitre of matrix
solution DHB (2,5-dihydroxybenzoic acid, 50 mg/mL, 30%
acetonitrile, 0.1% triﬂuoroacetic acid) was then added and
allowed to co-cristallize with the sample. Samples were pro-
cessed in the MALDI-TOF-MS spectrometer (Autoﬂex,
Bruker Daltonics) with the ﬂex control software (Bruker
Daltonics). Positive ions were extracted with an accelerating
voltage of 20 kV in linear mode. Each spectrum was the sum
of the ions obtained from 200 laser shots performed in ﬁve
different regions of the same well. The spectra have been
analyzed in the m/z range of 2000–20 000. The analysis was
performed with the ﬂex analysis software and calibrated with
protein calibration standard I (Bruker Daltonics). The data
obtained with the two replicates were added to minimize
any random effect. The presence and absence of peaks were
considered as ﬁngerprints for a particular isolate. The pro-
ﬁles were analyzed and compared using the BGP database
(http://sourceforge.net/projects/bgp). Identiﬁcation of CoNS
isolates was performed as previously described [15], and
corresponds to the species of the reference strain with the
best match in the database.
Statistical analysis
Results obtained with the Phoenix and MALDI-TOF-MS anal-
yses were grouped into three categories: (i) correct ID when
the identiﬁcation was identical to that obtained by molecular
identiﬁcation; (ii) misidentiﬁcation (Mis-ID) when the identiﬁ-
cation was different from that obtained by molecular identiﬁ-
cation; and (iii) absence of ID (no-ID) when no identiﬁcation
could be obtained. Results of the VITEK-2 system were
expressed as: (i) correct ID (excellent, very good, good or
acceptable ID) when the identiﬁcation was identical to that
found with the molecular technique; (ii) low-discrimination
ID when more than one identiﬁcation was proposed, thus
requiring additional tests for a precise identiﬁcation; and (iii)
Mis-ID and (iv) no-ID (see above).
Results
All isolates were identiﬁed at the species level. The sequenc-
ing of the sodA gene did not allow the species identiﬁcation
of two CoNS clinical isolates. For these two isolates, the
highest homology was with Staphylococci condimenti and
Staphylococci piscifermentans (85% identity at the nucleotide
level). We assumed that these two isolates belong to a new
species and they were excluded from the present study. The
species corresponding to the remaining 234 isolates are
shown in Table 1.
These isolates were then identiﬁed using MALDI-TOF-
MS and the two automated systems as described previ-
ously. Correct ID results were obtained for 93.2% (218/
234), 75.6% (177/234) and 75.2% (176/234) with MALDI-
TOF-MS, Phoenix and VITEK-2, respectively. Mis-ID rates
were 1.7% (4/234), 23.1% (54/234) and 13.7% (32/234),
respectively. The percentage of strains with no-ID was
5.1% (12/234), 1.3% (3/234) and 0.9% (2/234), respectively.
With VITEK-2, low-discrimination ID results were obtained
for an additional 10.3% (24/234) of the isolates. A correct
ID (100%) of all strains in all three systems was obtained
for only two species, Staphylococci sciuri sciuri and Staphylo-
cocci xylosus.
TABLE 2. Species included in the databases of the matrix-
assisted laser desorption/ionization-time of ﬂight mass spec-
trometry (MALDI-TOF-MS), Phoenix and VITEK-2 systems
Species
Identiﬁcation system
MALDI-
TOF-MS Phoenix VITEK-2
Staphylococci arlettae ) ) +
Staphylococci aureus + + +
Staphylococci auricularis + + +
Staphylococci capitis + + +
Staphylococci capitis spp. capitis + + )
Staphylococci capitis spp. urealyticus + + )
Staphylococci caprae + + +
Staphylococci carnosus ssp. carnosus ) + +
Staphylococci chromogenes ) + +
Staphylococci cohnii + + +
Staphylococci cohnii ssp. cohnii + + +
Staphylococci cohnii ssp. ureolyticum + + +
Staphylococci condimenti ) ) )
Staphylococci epidermidis + + +
Staphylococci equorum ) + +
Staphylococci felis ) + )
Staphylococci gallinarum ) + +
Staphylococci haemolyticus + + +
Staphylococci hominis + + +
Staphylococci hominis spp. hominis + ) )
Staphylococci hominis spp.
novobiosepticus
+ ) )
Staphylococci hyicus ) + +
Staphylococci intermedius + + +
Staphylococci kloosii ) + +
Staphylococci lentus + + +
Staphylococci lugdunensis + + +
Staphylococci pasteuri + + +
Staphylococci piscifermentans ) ) )
Staphylococci pseudintermedius ) ) )
Staphylococci saccharolyticus ) ) )
Staphylococci saprophyticus + + +
Staphylococci saprophyticus spp. bovis + ) )
Staphylococci saprophyticus spp.
saprophyticus
+ ) )
Staphylococci schleiferi + + +
Staphylococci schleiferi spp. coagulans + + )
Staphylococci schleiferi spp. schleiferi + + )
Staphylococci sciuri + + +
Staphylococci simulans + + +
Staphylococci vitulinus ) + +
Staphylococci warneri + + +
Staphylococci xylosus + + +
Species included in the study are indicated in bold.
+, Presence of the database in the ID system; ), absence of the database in the
ID system.
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The databases of the different ID systems tested are not
comprehensive and some CoNS could not be identiﬁed cor-
rectly using these identiﬁcation systems (Table 2). Three spe-
cies (S. condimenti, S. piscifermentans, S. saccharolyticus),
corresponding to nine isolates, could not be identiﬁed using
MALDI-TOF-MS and the Phoenix and VITEK-2 automated
systems. In addition, Staphylococci equorum, corresponding to
one isolate, could not be identiﬁed using MALDI-TOF-MS.
Among those strains, MALDI-TOF-MS gave nine out of ten
no-ID and one Mis-ID. On the other hand, the identiﬁcation
was a Mis-ID for six and nine strains with the Phoenix and
VITEK-2 automated systems, respectively. The results were
then compared after excluding the ten strains that could
not be properly identiﬁed using at least one of the three ID-
systems under study (Table 1). A correct identiﬁcation was
obtained in 97.4% (218/224), 79% (177/224) and 78.6% (176/
224) using MALDI-TOF-MS, Phoenix and VITEK-2, respec-
tively. Mis-ID occurred in 1.3% (3/224), 21% (47/225) and
10.3% (23/224) with MALDI-TOF-MS, Phoenix and VITEK-2,
respectively. However, it should be noted that, with the
VITEK-2 system, 10.3% (23/224) of the isolates were identi-
ﬁed with remote possibility. Rates of no-ID results were low
with all systems: 1.3% (3/225), 0% (0/225) and 0.9% (2/225)
with MALDI-TOF-MS, Phoenix and VITEK-2, respectively.
For the ﬁve species that most frequently cause diseases in
humans or are isolated from human samples, S. epidermidis
(n = 56), S. hominis (n = 29), S. haemolyticus (n = 14), S. lug-
dunensis (n = 14) and S. saprophyticus (n = 12), MALDI-TOF-
MS gave a correct identiﬁcation in 98.4% (123/125), Phoenix
in 86.4% (108/125) and VITEK-2 in 88% (110/125) of cases.
Discussion
This is the ﬁrst report of a direct comparison between two
automated systems, VITEK-2 and BD Phoenix, and MALDI-
TOF-MS for the identiﬁcation of coagulase-negative staphylo-
cocci. Because of the increasing clinical signiﬁcance of CoNS,
accurate species identiﬁcation is highly desirable to permit a
more precise determination of the host–pathogen relation-
ship of CoNS.
Phenotypic identiﬁcation of CoNS appears to be unsatis-
factory, unreliable and irreproducible. Misidentiﬁcation is a
consequence of the heterogeneity of the CoNS population
obtained from clinical specimens [19]. Additionally, the fact
that identiﬁcation of CoNS is not as reliable as that of Staph-
ylococci aureus might be explained by their slow metabolism,
leading to ambiguous results in the reaction wells of the ID
panel, as shown in several studies [2,5–7,16]. Different ﬁnd-
ings have been published on the ability of the Phoenix and
VITEK-2 systems to identify CoNS. In several studies, no ref-
erence identiﬁcation, such as sequencing of the sodA gene
[8,9], was used.
Correct identiﬁcations obtained with the VITEK-2 system
vary in the range 74–97% [17,18,21–23] and 61–98%
with Phoenix identiﬁcation system [24–26]. This important
variation could be explained by the fact that strain collections
used are not homogenous in the number of isolates per spe-
cies and in the number of species tested, with some being
overrepresented. In several comparative studies, CoNS spe-
cies representativity may vary in the range 74–91% for only
three species (i.e. S. epidermidis, S. hominis and S. haemolyticus)
[17,18,24,27]. In the present study, only 42% of the tested iso-
lates belonged to these three species, thus allowing a greater
diversity of CoNS species to be evaluated. We obtained cor-
rect identiﬁcation in 75.2% with VITEK-2 and in 75.6% with
Phoenix compared to 93.2% obtained with MALDI-TOF-MS.
Overall, ID accuracy for CoNS was in the range 91–96%
[17,18,21,23] with VITEK-2, and 61–98% [24–27] with Phoe-
nix. Published sensitivity values were higher than those
reported in the present study, which might be explained by
differences in strain collections.
Recently, Layer et al. [27], comparing VITEK-2, Phoenix
and API32 Staph, used a collection of 86 strains of CoNS
including S. epidermidis (n = 42), S. haemolyticus (n = 30) and
S. hominis (n = 4), which made up 88% of all strains.
This sampling difference might explain higher sensitivity val-
ues for both Phoenix and VITEK-2 compared to the present
study. Finally, Eigner et al. [28] used a collection of 93 strains
of staphylococci, with few details regarding identiﬁcation per
species, and both automates yielded similar results of correct
ID (97%). In addition, Delmas et al. [22] obtained a correct
identiﬁcation of 71.2% for clinical and environmental CoNS
with the VITEK-2 ID system and 82.5% when isolates belong-
ing to species absent from the automate database were
excluded. In that study, S. epidermidis, S. hominis and S. haemo-
lyticus represented only 21.9% of the 146 strains belonging to
21 species of CoNS, which is in better agreement with our
collection and the results obtained in the present study.
A low-inoculum approach with the Phoenix system [29]
allowed working directly from primary cultures with fewer
colonies. Particularly good performances were observed
recently [30] with regard to S. epidermidis (96%), S. sap-
rophyticus (100%) and S. haemolyticus (97.5%), although a
lower accuracy was obtained with S. hominis (69.6%).
MALDI-TOF-MS gave a correct ID of the isolates belonging
to those species in 100%, 100%, 85.8% and 100%, respec-
tively, in the present study.
The data in the present study show that, using MS, a cor-
rect identiﬁcation was obtained for 93.2% of the isolates and,
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after excluding those belonging to species that were not
included in the database, correct identiﬁcation was obtained
for 97.4% of CoNS. It should be noted that the correct ID
of S. hominis is low with the different automated systems
[16,18], although 100% of the isolates used in the present
study were correctly identiﬁed using MALDI-TOF-MS.
Compared to other studies, the ID results obtained for the
same species with the MALDI-TOF-MS are better or identi-
cal for S. epidermidis (100%), S. saprophyticus (100%) and
S. hominis (100%), except for S. haemolyticus (85.8%). For the
other species, the results are better or similar, although the
low numbers of isolates do not allow any ﬁrm conclusion to
be drawn.
For the strains that could not be identiﬁed because data-
bases allowing identiﬁcation were not present, no identiﬁca-
tion was obtained in the MALDI-TOF-MS system, except in
one case compared to the other two systems that, in most
cases, gave a misidentiﬁcation.
Furthermore, a database for MALDI-TOF-MS identiﬁcation
can easily be updated. For example, to identify S. saccharolyti-
cus, we created the database with one strain of S. saccharolyt-
icus according to the strategy that we had previously
described [15], allowing us to identify the other with 100%
correct identiﬁcation (data not shown).
We had previously demonstrated that MALDI-TOF-MS
is a powerful tool for the identiﬁcation of clinically rele-
vant species of CoNS [15] and nonfermenting Gram nega-
tive bacilli isolated from cystic ﬁbrosis patients [20]. The
results obtained in the present study demonstrate the
higher performances of this technology in the identiﬁcation
of CoNS compared to two commercial systems largely
used for routine identiﬁcation. In addition, the absence of
panels or speciﬁc ID reagents reduced the cost of the
analysis compared to the two other tested techniques.
Finally, implementation of the database with new species is
extremely simple, allowing the updating of the database.
The present study strengthens the role of MALDI-TOF-MS
in the microbiology laboratory and supports its use in the
routine laboratory.
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